Janux Therapeutics, Inc.(JANX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

JANX Janux Therapeutics, Inc.

交易中 11-19 15:22:22 EST

49.01

+0.89

+1.84%

最高49.74	最低47.70	成交量38.88万
今开48.35	昨收48.12	日振幅4.23%
总市值25.72亿	流通市值18.62亿	总股本5,248万
成交额1,897万	换手率1.02%	流通股本3,800万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"JANX","market":"US","secType":"STK","nameCN":"Janux Therapeutics, Inc.","latestPrice":49.0075,"timestamp":1732047735372,"preClose":48.12,"halted":0,"volume":388777,"delay":0,"floatShares":38004235,"shares":52479737,"eps":-1.186212,"marketStatus":"交易中","marketStatusCode":2,"change":0.8875,"latestTime":"11-19 15:22:22 EST","open":48.35,"high":49.735,"low":47.7,"amount":18972093.275670998,"amplitude":0.04229,"askPrice":49.06,"askSize":35,"bidPrice":48.98,"bidSize":163,"shortable":3,"etf":0,"ttmEps":-1.186212,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1732050000000},"adr":0,"listingDate":1623384000000,"adjPreClose":48.12,"preHourTrading":{"tag":"盘前","latestPrice":48.6,"preClose":48.12,"latestTime":"09:28 EST","volume":18,"amount":876.8233799999999,"timestamp":1732026504765},"postHourTrading":{"tag":"盘后","latestPrice":48.12,"preClose":48.12,"latestTime":"19:00 EST","volume":7610,"amount":366196.86,"timestamp":1731974434420},"volumeRatio":0.840574,"impliedVol":1.1439,"impliedVolPercentile":0.754},"requestUrl":"/m/hq/s/JANX/wiki","defaultTab":"wiki","newsList":[{"id":"2482526779","title":"Janux Therapeutics, Inc.2024财年第三财季实现净利润-28.06百万美元，同比减少142.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482526779","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482526779?lang=zh_cn&edition=full","pubTime":"2024-11-11 00:00","pubTimestamp":1731254426,"startTime":"0","endTime":"0","summary":"11月11日，Janux Therapeutics, Inc.公布财报，公告显示公司2024财年第三财季净利润为-28.06百万美元，同比减少142.52%；其中营业收入为439000.00美元，同比减少82.58%，每股基本收益为-0.51美元。从资产负债表来看，Janux Therapeutics, Inc.总负债38.92百万美元，其中短期债务1.69百万美元，资产负债比为0.18，流动比率为0.39。机构评级：截至2024年11月11日，当前有10家机构对Janux Therapeutics, Inc.目标价做出预测，其中目标均价为66.10美元，其中最低目标价为25.00美元，最高目标价为100.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111000034abb36215&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111000034abb36215&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","JANX"],"gpt_icon":0},{"id":"2481534486","title":"Janux Therapeutics, Inc.盘中异动 急速上涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481534486","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481534486?lang=zh_cn&edition=full","pubTime":"2024-11-05 01:38","pubTimestamp":1730741934,"startTime":"0","endTime":"0","summary":"北京时间2024年11月05日01时38分，Janux Therapeutics, Inc.股票出现异动，股价急速上涨5.00%。Janux Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Neurogene Inc.、Tenaya Therapeutics, Inc.、Disc Medicine, Inc.涨幅较大，Elevai Labs, Inc.、Nls Pharmaceutics Ltd.、Gri Bio, Inc.较为活跃，换手率分别为375.10%、275.26%、79.71%，振幅较大的相关个股有Sab Biotherapeutics Inc C/Wts 22/10/2026 、In8Bio, Inc.、Neurogene Inc.，振幅分别为52.25%、45.39%、39.98%。Janux Therapeutics, Inc.公司简介：Janux Therapeutics Inc 是一家临床阶段的生物制药公司，基于专有的肿瘤激活 T Cell Engager 平台技术开发下一代疗法，以更好地治疗癌症患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105013854a21599a4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105013854a21599a4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","JANX","BK4139","BK4539"],"gpt_icon":0},{"id":"2478594519","title":"Janux Therapeutics, Inc.盘中异动 急速上涨5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478594519","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478594519?lang=zh_cn&edition=full","pubTime":"2024-10-26 00:44","pubTimestamp":1729874675,"startTime":"0","endTime":"0","summary":"北京时间2024年10月26日00时44分，Janux Therapeutics, Inc.股票出现异动，股价急速拉升5.10%。Janux Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.83%。Janux Therapeutics, Inc.公司简介：Janux Therapeutics Inc 是一家临床阶段的生物制药公司，基于专有的肿瘤激活 T Cell Engager 平台技术开发下一代疗法，以更好地治疗癌症患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102600443698e3e8d8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102600443698e3e8d8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["JANX","BK4139","BK4539","LENZ"],"gpt_icon":0},{"id":"2477308527","title":"美股异动丨Janux Therapeutics盘前涨4% 获董事增持超5千万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477308527","media":"港股那点事","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477308527?lang=zh_cn&edition=full","pubTime":"2024-10-23 17:07","pubTimestamp":1729674420,"startTime":"0","endTime":"0","summary":"Janux Therapeutics(JANX.US)盘前涨4%报54.9美元。根据美国证券交易委员会(SEC)10月22日披露的文件，Janux Therapeutics董事RA CAPITAL MANAGEMENT, L.P.于10月18日以每股平均价44.75美元增持120万股普通股股份，价值约为5,370万美元。(格隆汇)\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/bxjj/2024-10-23/doc-inctpriw0723764.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/bxjj/2024-10-23/doc-inctpriw0723764.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["JANX","BK4139","LENZ","BK4539"],"gpt_icon":0},{"id":"2474740345","title":"Janux Therapeutics, Inc.盘中异动 急速拉升5.21%报46.45美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2474740345","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474740345?lang=zh_cn&edition=full","pubTime":"2024-10-09 00:47","pubTimestamp":1728406024,"startTime":"0","endTime":"0","summary":"北京时间2024年10月09日00时47分，Janux Therapeutics, Inc.股票出现异动，股价大幅拉升5.21%。截至发稿，该股报46.45美元/股，成交量19.7065万股，换手率0.38%，振幅4.62%。Janux Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.14%。Janux Therapeutics, Inc.公司简介：Janux Therapeutics Inc 是一家临床阶段的生物制药公司，基于专有的肿瘤激活 T Cell Engager 平台技术开发下一代疗法，以更好地治疗癌症患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100900470498e3b386&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100900470498e3b386&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["JANX","BK4139","LENZ","BK4539"],"gpt_icon":0},{"id":"2458692137","title":"Janux Therapeutics, Inc.2024财年第二财季实现净利润-5.96百万美元，同比增加65.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2458692137","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458692137?lang=zh_cn&edition=full","pubTime":"2024-08-12 00:10","pubTimestamp":1723392638,"startTime":"0","endTime":"0","summary":"8月12日，Janux Therapeutics, Inc.公布财报，公告显示公司2024财年第二财季净利润为-5.96百万美元，同比增加65.96%；其中营业收入为8.90百万美元，同比增加739.62%，每股基本收益为-0.11美元。从资产负债表来看，Janux Therapeutics, Inc.总负债33.74百万美元，其中短期债务1.63百万美元，资产负债比为0.21，流动比率为0.58。机构评级：截至2024年8月12日，当前有8家机构对Janux Therapeutics, Inc.目标价做出预测，其中目标均价为67.25美元，其中最低目标价为42.00美元，最高目标价为100.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081200104195904260&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081200104195904260&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["JANX","LENZ"],"gpt_icon":0},{"id":"2455861866","title":"Janux Therapeutics, Inc.盘中异动 大幅跳水5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2455861866","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455861866?lang=zh_cn&edition=full","pubTime":"2024-07-30 03:45","pubTimestamp":1722282328,"startTime":"0","endTime":"0","summary":"北京时间2024年07月30日03时45分，Janux Therapeutics, Inc.股票出现波动，股价大幅跳水5.00%。Janux Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.07%。Janux Therapeutics, Inc.公司简介：Janux Therapeutics Inc 是一家临床阶段的生物制药公司，基于专有的肿瘤激活 T Cell Engager 平台技术开发下一代疗法，以更好地治疗癌症患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240730034528af94a6ae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240730034528af94a6ae&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","JANX","BK4139","LENZ"],"gpt_icon":0},{"id":"2454372045","title":"Janux Therapeutics, Inc.盘中异动 急速上涨5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2454372045","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454372045?lang=zh_cn&edition=full","pubTime":"2024-07-27 03:40","pubTimestamp":1722022805,"startTime":"0","endTime":"0","summary":"北京时间2024年07月27日03时40分，Janux Therapeutics, Inc.股票出现异动，股价急速上涨5.12%。Janux Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.02%。Janux Therapeutics, Inc.公司简介：Janux Therapeutics Inc 是一家临床阶段的生物制药公司，基于专有的肿瘤激活 T Cell Engager 平台技术开发下一代疗法，以更好地治疗癌症患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240727034005af945e48&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240727034005af945e48&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","LENZ","JANX"],"gpt_icon":0},{"id":"2454382913","title":"成分股MeiraGTx收涨11.62%，AC Immune涨10.76%，诺瓦瓦克斯医药涨8.25%表现第三，和黄医药则收跌3.","url":"https://stock-news.laohu8.com/highlight/detail?id=2454382913","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454382913?lang=zh_cn&edition=full","pubTime":"2024-07-26 04:45","pubTimestamp":1721940358,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"live_wallstreetcn","url":"https://wallstreetcn.com/live/a-stock","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wallstreetcn.com/live/a-stock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_wallstreetcn","symbols":["BK1587","BK4588","BK4531","00013","BK4568","BK4585","NVAX","BK4547","JANX","LENZ","BK4007","BK4539","BK4139","HCM","BK1588","BK1191","EWTX","BK4135","AC"],"gpt_icon":0},{"id":"2451071918","title":"Janux Therapeutics, Inc.盘中异动 早盘大幅拉升5.04%报45.66美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2451071918","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2451071918?lang=zh_cn&edition=full","pubTime":"2024-07-16 21:50","pubTimestamp":1721137822,"startTime":"0","endTime":"0","summary":"北京时间2024年07月16日21时50分，Janux Therapeutics, Inc.股票出现波动，股价快速上涨5.04%。截至发稿，该股报45.66美元/股，成交量2.8974万股，换手率0.06%，振幅3.36%。Janux Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.54%。Janux Therapeutics, Inc.公司简介：Janux Therapeutics Inc 是一家临床阶段的生物制药公司，基于专有的肿瘤激活 T Cell Engager 平台技术开发下一代疗法，以更好地治疗癌症患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407162150229681d31e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407162150229681d31e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","LENZ","JANX"],"gpt_icon":0},{"id":"2442544552","title":"Janux Therapeutics, Inc.盘中异动 快速拉升5.69%报44.43美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2442544552","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2442544552?lang=zh_cn&edition=full","pubTime":"2024-06-12 21:31","pubTimestamp":1718199097,"startTime":"0","endTime":"0","summary":"北京时间2024年06月12日21时31分，Janux Therapeutics, Inc.股票出现波动，股价大幅拉升5.69%。截至发稿，该股报44.43美元/股，成交量4517股，换手率0.01%，振幅0.00%。Janux Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.34%。Janux Therapeutics, Inc.公司简介：Janux Therapeutics Inc 是一家临床阶段的生物制药公司，基于专有的肿瘤激活 T Cell Engager 平台技术开发下一代疗法，以更好地治疗癌症患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061221313896813b09&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061221313896813b09&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["JANX","BK4539","LENZ","BK4139"],"gpt_icon":0},{"id":"2441265826","title":"成分股阿玛琳（AMRN）收跌17.91%，Summit Therapeutics Plc.、23Andme Holding Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2441265826","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2441265826?lang=zh_cn&edition=full","pubTime":"2024-06-05 05:25","pubTimestamp":1717536302,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"live_wallstreetcn","url":"https://wallstreetcn.com/live/a-stock","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wallstreetcn.com/live/a-stock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_wallstreetcn","symbols":["BK4526","BK1574","BK4539","LENZ","BK4588","BK4007","BK4585","AMRN","BK1191","BK1161","BK4531","JANX","BK1587","BK1588","00013","HCM","BK4139","09688","ZLAB","BK4548"],"gpt_icon":0},{"id":"2440235195","title":"Janux Therapeutics, Inc.盘中异动 股价大跌5.00%报52.23美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2440235195","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2440235195?lang=zh_cn&edition=full","pubTime":"2024-06-04 21:42","pubTimestamp":1717508553,"startTime":"0","endTime":"0","summary":"北京时间2024年06月04日21时42分，Janux Therapeutics, Inc.股票出现异动，股价急速跳水5.00%。截至发稿，该股报52.23美元/股，成交量1.9957万股，换手率0.04%，振幅3.62%。Janux Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.05%。Janux Therapeutics, Inc.公司简介：Janux Therapeutics Inc 是一家临床阶段的生物制药公司，基于专有的肿瘤激活 T Cell Engager 平台技术开发下一代疗法，以更好地治疗癌症患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240604214233af8beeb6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240604214233af8beeb6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["JANX","BK4139","BK4539","LENZ"],"gpt_icon":0},{"id":"2439918815","title":"Janux Therapeutics, Inc.盘中异动 早盘急速拉升5.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2439918815","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2439918815?lang=zh_cn&edition=full","pubTime":"2024-05-31 22:14","pubTimestamp":1717164868,"startTime":"0","endTime":"0","summary":"北京时间2024年05月31日22时14分，Janux Therapeutics, Inc.股票出现异动，股价快速上涨5.24%。Janux Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.16%。Janux Therapeutics, Inc.公司简介：Janux Therapeutics Inc 是一家临床阶段的生物制药公司，基于专有的肿瘤激活 T Cell Engager 平台技术开发下一代疗法，以更好地治疗癌症患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405312214289681121d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405312214289681121d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","JANX","BK4139","BK4539"],"gpt_icon":0},{"id":"2439251623","title":"Janux Therapeutics(JANX.US)获Scotiabank首次覆盖，给予与大盘持平评级, 目标价47.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2439251623","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2439251623?lang=zh_cn&edition=full","pubTime":"2024-05-30 22:36","pubTimestamp":1717079813,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4139","BK4539","JANX","LENZ"],"gpt_icon":0},{"id":"2439616174","title":"Janux Therapeutics Inc：丰业银行以行业表现评级和47美元的目标股价启动保险","url":"https://stock-news.laohu8.com/highlight/detail?id=2439616174","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2439616174?lang=zh_cn&edition=full","pubTime":"2024-05-30 18:11","pubTimestamp":1717063885,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4139","BK4207","JANX","BNS","LENZ","BK4539"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.januxrx.com","stockEarnings":[{"period":"1week","weight":-0.1036},{"period":"1month","weight":-0.0382},{"period":"3month","weight":0.0712},{"period":"6month","weight":0.0611},{"period":"1year","weight":4.5438},{"period":"ytd","weight":3.4846}],"compareEarnings":[{"period":"1week","weight":-0.0177},{"period":"1month","weight":0.0061},{"period":"3month","weight":0.0527},{"period":"6month","weight":0.1101},{"period":"1year","weight":0.3047},{"period":"ytd","weight":0.2374}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Janux Therapeutics, Inc.于2017年6月27日在特拉华州注册成立。该公司是一家创新的生物制药公司，开发基于该公司专有的肿瘤激活T细胞接合器（TRACTr）平台技术的下一代疗法，以更好地治疗癌症患者。该公司最初的重点是开发一类新的T细胞接合器（TCE），该公司的主要候选产品是针对临床验证的药物靶点设计的。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":0.085364},{"month":2,"riseRate":0.666667,"avgChangeRate":1.511745},{"month":3,"riseRate":0,"avgChangeRate":-0.221441},{"month":4,"riseRate":0.666667,"avgChangeRate":0.155417},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.057273},{"month":6,"riseRate":0.666667,"avgChangeRate":-0.03282},{"month":7,"riseRate":0.75,"avgChangeRate":0.116412},{"month":8,"riseRate":0.5,"avgChangeRate":-0.033618},{"month":9,"riseRate":0.25,"avgChangeRate":-0.057733},{"month":10,"riseRate":0.75,"avgChangeRate":0.071595},{"month":11,"riseRate":0.25,"avgChangeRate":-0.066075},{"month":12,"riseRate":0.666667,"avgChangeRate":0.101437}],"exchange":"NASDAQ","name":"Janux Therapeutics, Inc.","nameEN":"Janux Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Janux Therapeutics, Inc.(JANX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Janux Therapeutics, Inc.(JANX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Janux Therapeutics, Inc.,JANX,Janux Therapeutics, Inc.股票,Janux Therapeutics, Inc.股票老虎,Janux Therapeutics, Inc.股票老虎国际,Janux Therapeutics, Inc.行情,Janux Therapeutics, Inc.股票行情,Janux Therapeutics, Inc.股价,Janux Therapeutics, Inc.股市,Janux Therapeutics, Inc.股票价格,Janux Therapeutics, Inc.股票交易,Janux Therapeutics, Inc.股票购买,Janux Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Janux Therapeutics, Inc.(JANX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Janux Therapeutics, Inc.(JANX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}